The PhD in Pharmacology from the Complutense University of Madrid was recognized for his research on the biomedical use of cannabis and cannabinoids.

La Universidad Nacional de Rosario awarded the Honoris Causa Doctorate Degree to Dr. Jorge Manzanares Robles in a ceremony that took place at the University Cultural Space. It was chaired by the Vice-Rector Héctor Darío Masía and the dean of the Faculty of Dentistry Gabriela Pisterna, godmother of the honoree.

“For those of us who belong to the health area and especially to teaching and research in pharmacology, we are proud of the presence of Dr. Manzanares Robles because we identify him as our benchmark in the scientific advancement of knowledge about the biomedical use of cannabis and cannabinoids and because He is recognized for his human qualities in the American and European continents as a teacher", expressed in the laudatio Dr. Adriana Martínez, Full Professor of the Chair of Pharmacology of the Faculty of Dentistry of the UNR who highlighted: "For him the medicine It never ceased to be a social good, it will never be a consumer good”.   

“It is a very exciting moment for me and it is also a great honor and responsibility that I can join with this important link to the UNR and be able to contribute to the work that is being developed. I will do everything possible to achieve the mark of quality, honesty and academic value that this public institution deserves", expressed the honoree who, after acknowledging, gave a lecture entitled "The role of pharmacology to normalize behavior in psychiatric disorders and in the adictions".

During June 8 and 9, Manzanares Robles will preside over the First International Symposium on the Use of Cannabis and Cannabinoid Derivatives organized by the UNR and the Miguel Hernández University of Elche (Spain).

path

Dr. Manzanares Robles graduated in Pharmacy from the Complutense University of Madrid in 1985 and received his doctorate in Pharmacology from the Faculty of Pharmacy in 1987. During this phase he also worked in the research and psychiatry service of the Ramón y Cajal Hospital in Madrid and in the biochemistry service of the La Paz Hospital in Madrid. From 1988 to the end of 1993 he was a researcher at the Department of Pharmacology and Toxicology at Michigan State University in the USA. Upon his return to Spain, he worked as a researcher hired by the Ministry of Education and the Ministry of Health.

He was principal investigator of more than 45 projects on animal modeling and clinical studies financed with public and private funds. He received the Research Performance Award for Professors from the Miguel Hernández University and the 2016 Award from the Ibero-American Academy of Pharmacy. He has published more than 200 scientific articles in international journals and book chapters on different aspects of the neuropsychopharmacology of neuropsychiatric diseases. He has more than 6800 citations.

He presented 270 communications to national and international conferences and was invited to give more than 200 scientific conferences in Spain, the United Kingdom, France, the Netherlands, Sweden, Switzerland, Germany, Malta, Portugal, Russia, Belgium, Italy, Canada, the USA, Argentina, Costa Rica, Colombia, Mexico, Bolivia, Cuba, Ecuador, Panama, Peru, Brazil, among others.

With his research group, he is part of the 2017-2021 National Network of addictive disorders for groups of excellence of the Spanish Ministry of Health. Since 2011 he is Professor of Pharmacology and Dean of the Faculty of Pharmacy of the Miguel Hernández University on the San Juan de Alicante Campus. In 2019, he was named academic of the Royal National Academy of Pharmacy of Spain, of the National Academy of Pharmaceutical Sciences of Mexico, and of the Mexican Academy of Psychiatry and Mental Health.

Journalist: Victoria Arrabal/Photographer: Pablo Correa.